/

Sociétés

Ce

Non vérifié

Cellares

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueMarché du travailSanté

18 communiqués de presse

Voir tous les communiqués de presse

28/01/2026

Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation

Source

Émetteur

1.00

0

12/01/2026

Marché du travail

Industrie

Biotechnologie

Santé Publique

Santé

Industrie pharmaceutique

Science

Cellares amplia la rete globale di Smart Factory con una sede centrale europea nei Paesi Bassi

Source

Émetteur

1.00

0

12/01/2026

Industrie

Santé

Biotechnologie

Médecine - Divers

Science

Industrie pharmaceutique

IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms

Source

Émetteur

1.00

0

12/01/2026

Marché du travail

Industrie

Biotechnologie

Santé Publique

Santé

Industrie pharmaceutique

Science

Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands

Source

Émetteur

1.00

0

08/01/2026

Science

Santé Publique

Industrie pharmaceutique

Oncologie

Industrie

Biotechnologie

Santé

Marché du travail

Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy

Source

Émetteur

1.00

0

01/12/2025

Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO

Source

Émetteur

1.00

0

22/09/2025

Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors

Source

Émetteur

1.00

0

17/09/2025

Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

Source

Émetteur

1.00

0

29/05/2025

Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing in Japan

Source

Émetteur

1.00

0

10/04/2025

Marché du travail

Industrie

Science

Industrie pharmaceutique

Oncologie

Université

Biotechnologie

École/Enseignement

Médecine - Divers

Santé

Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors

Source

Émetteur

1.00

0

Followers

0

Compatibilité

0